A pilot study of ketamine among individuals with tobacco use disorder: tolerability and initial impact on tobacco use outcomes.
Journal of Addictive Diseases January 20, 2025 Janice Chuang, Riley Carpenter Lide, Nikhil Kamath et al. 3 citations
There is increasing evidence of ketamine's therapeutic potential in reducing substance use in individuals with substance use disorders. However, its effects on tobacco use disorder are unknown. We investigated the effect of a subanesthetic dose of ketamine on tobacco use. This randomized, single-blind, placebo-controlled, pilot study administered intravenous ketamine to individuals with tobacco...